Polaris Market Research today announced findings from its latest report, projecting the global Stable Isotope Labeled Compounds Market to grow from USD 283.19 million in 2022 to USD 394.86 million by 2032, at a CAGR of 3.4%. The 115-page report profiles eight leading companies across four segmentation categories, giving buyers and investors a clear view of market size, market share and industry trends.

Analyst Commentary on Stable Isotope Labeled Compounds Growth

“Growing demand for new drug development and clinical research, together with the rising prevalence of cancer, is the clearest driver of market growth,” said a Polaris Market Research analyst. “Advances in mass spectrometry are widening the use of labeled compounds across proteomics, metabolomics and environmental testing, and the strongest opportunity lies with suppliers serving pharmaceutical, biotech and research customers.”

Stable Isotope Labeled Compounds Market Statistics at a Glance

• 2022 Market Size: USD 283.19 million
• 2032 Projected Size: USD 394.86 million
• CAGR (2023-2032): 3.4%
• Largest Region: North America is expected to dominate revenue share; Asia Pacific is projected to grow faster
• Largest Application (2022): Research; Carbon 13 is expected to be the fastest-growing type

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: Growing demand for new drug development and clinical research, an increasing focus on personalized medicine, and the rising prevalence of cancer are the primary forces behind the market's expansion, alongside growing demand for proteomics, metabolomics and environmental testing. The American Cancer Society projected 609,360 cancer deaths and about 1.9 million new cancer cases in the United States in 2022, while Indian pharmaceutical exports rose 103% between 2013-14 and 2021-22. Many governments are also increasing funding for cancer research. High cost remains the key restraint.

Major Companies Covered: PerkinElmer, Merck KGaA, Cambridge Isotope Laboratories, JSC Isotope, Medical Isotopes, Omicron Biochemicals, Trace Sciences International, and Taiyo Nippon Sanso Corporation.

Segments Covered: By Type (Deuterium, Carbon 13, Oxygen 18, Nitrogen 15), By Application (Research, Clinical Diagnostics, Industrial), By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Hospitals and Diagnostic Centres), and By Region.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/stable-isotope-labeled-compounds-market 

Segment Insights: Carbon 13, Research and Pharma-Biotech

Carbon 13 is expected to be the fastest-growing type, as carbon-13 labeling supports proteomics, metabolomics and lipidomics, which are critical to personalized medicine, and as better mass spectrometry improves the accuracy and sensitivity of analysis. The research application held the largest share in 2022, supported by rising research funding across pharmaceuticals, biotechnology and environmental testing and by the use of labeled compounds in biomarker discovery. Pharmaceutical and biotechnology companies are expected to hold a significant revenue share, since labeled compounds help differentiate compounds and study metabolic pathways in living organisms.

Recent Developments in Stable Isotope Labeling

• June 2025: Thermo Fisher Scientific introduced the Orbitrap Astral Zoom and Orbitrap Excedion Pro mass spectrometers, with scan speeds up to 35% faster to support advanced stable isotope research.
• June 2025: ASP Isotopes raised USD 50 million through a public offering of 7.5 million shares priced at USD 6.65, for specialty isotope development and related projects.
• February 2023: PerkinElmer introduced the EnVision Nexus system, a multi-mode plate reader built for high-throughput screening in drug discovery.
• November 2022: Biotheus partnered with Merck, cutting cell line characterization turnaround from 60 to 14 days using Merck's Rodent Panel.

Regional Snapshot: North America Leads Revenue, Asia Pacific Fastest-Growing

North America is expected to dominate revenue share through the forecast period, supported by established healthcare infrastructure and high healthcare spending, with the United States spending more than USD 4 trillion on healthcare in 2020. Asia Pacific is projected to grow faster, driven by a growing focus on environmental testing, including water and soil analysis, as climate change and demand for clean energy gain attention; without action on climate, regional GDP could fall by as much as 3.3% by 2050.

Why It Matters for Stakeholders Tracking the Market Forecast to 2032

For stakeholders researching the stable isotope labeled compounds market forecast and its top companies, the underlying report benchmarks market share, company positioning, and segment-level forecasts from 2019 to 2032 to support sourcing, partnership, and investment decisions. It also includes Porter's Five Forces and PESTEL analysis, value chain and COVID-19 impact analysis, and country-level data covering 22 countries, with rivalry among existing firms rated high. Suppliers, laboratories and investors can use these insights to prioritize products and partnerships.

More Trending Latest Reports By Polaris Market Research:

Glass Mat Market

Influenza Medications Market

Animal Ultrasound Market

Prostaglandin Analogs Market

Influenza Medications Market

Digital Transaction Management Market

Gluten Free Breakfast Cereals Market

Rising Use of Advance Contraceptive Methods to Drive Growth

Carbon Capture and Storage Market